Breakthrough HIV viraemia on bictegravir/emtricitabine/tenofovir alafenamide in the third trimester of pregnancy

MeSH terms

• Adenine / administration & dosage
• Adenine / adverse effects
• Adenine / analogs & derivatives
• Alanine / administration & dosage
• Alanine / adverse effects
• Amides
• Anti-HIV Agents* / administration & dosage
• Anti-HIV Agents* / adverse effects
• Emtricitabine / administration & dosage
• Emtricitabine / adverse effects
• HIV Infections* / blood
• HIV Infections* / diagnosis
• HIV Infections* / drug therapy
• HIV Infections* / virology
• Heterocyclic Compounds, 3-Ring / administration & dosage
• Heterocyclic Compounds, 3-Ring / adverse effects
• Heterocyclic Compounds, 4 or More Rings / administration & dosage
• Heterocyclic Compounds, 4 or More Rings / adverse effects
• Humans
• Piperazines / administration & dosage
• Piperazines / adverse effects
• Pregnancy
• Pregnancy Complications, Infectious* / blood
• Pregnancy Complications, Infectious* / diagnosis
• Pregnancy Complications, Infectious* / drug therapy
• Pregnancy Complications, Infectious* / virology
• Pregnancy Trimester, Third*
• Pyridones / administration & dosage
• Pyridones / adverse effects
• Tenofovir / administration & dosage
• Tenofovir / adverse effects
• Tenofovir / analogs & derivatives
• Viremia* / blood
• Viremia* / diagnosis
• Viremia* / drug therapy
• Viremia* / virology